The Newswire

Your daily serving of financial goodness

Cash Converters and Money3 Have Reported - What You Need to Know

Cash Converters and Money3 Have Reported - What You Need to Know
Aug 28, 2015 By Simon Herrmann

Small credit lenders Money3 Corporation (ASX:MNY) and Cash Converters International (ASX:CCV) have released their full year results. Money3 announced a $13.9m profit up 78% to pcp, while Cash Converters revealed a staggering $21.7m loss due to one-off costs associated with class actions and impairment charges in its UK operations.

Money3 Corporation reported total revenue of $69.4m, an increase of nearly 60% compared to the previous corresponding period (pcp). This resulted in a 78% lift in net profit to $13.9m and a fully franked dividend of 2.75 cents. Earnings per share increased to 9.91 cents, giving MNY an attractive price to earnings ratio of 10.4, well below the marker average.

Money3 as well as its competitors were recently sold off as investors fear regulatory changes that could negatively impact small lenders. Fundamentally Wise-owl has a bearish view on the sector due to a combination of regulatory scrutiny, customer default risk, competition and vulnerability to interest rate rises. Bad publicity such as media reports about deceptive practices have helped accelerate the bearish sentiment.

Cash Converters announced a net loss of $21.7m compared to a FY14 profit of $21.1m just 12 months ago. Earnings per share came in negative at -4.69 cents per share. On the bright side revenue increased 13 per cent to $374.9m, roughly $43m more than last year.

Cash Converters terminated two agency agreements with Kentsleigh Pty Ltd and Cliffview Pty Ltd with an after tax impact of negative $16.8m

Other reason for the big loss are one-off costs associated with class actions. Cash Converters was ordered to pay $20m into a fund for distribution to members of the class plus additional legal costs of $3m. Also negative impacts from the UK legislative changes have affected Cash Converter’s UK operations and resulted in on-off costs to restructure the business as well as in an impairment charge.

No final dividend was declared due to “the application of the covenants under its banking facility.” The company states that underlying profit remains strong and cash resources are available, hence the company will try to replace the current bank facilities but it has yet to be confirmed.

CCV fell 12% today following the release of the results and is down 55.7% year-to-date. MNY rose around 3% is hovering just above the $1 mark. Wise-owl recommended to sell MNY on 30 March at $1.37 after technical support was broken.

 

Share this article

Simon Herrmann Author: Simon Herrmann Aug 28, 2015

Simon is a financial analyst at independent research firm Wise-owl who wants to change the world by disrupting the cliché approach to investment decision making with convergent thinking. Wise-owl’s goal is plain and simple: Find the best opportunities for our members by following a proven methodology and to create long-term value through high-quality advice, innovation, technology and education. We combine industry experience and the agile mentality of a start-up. Wise-owl is the future of stock market investing.

Growing Cases of Cancer Fuel Demand for Diagnostic Technology: Sienna Cancer IPO

The Australian government estimates that over 130,000 new cancer cases will be diagnosed in 2017 and the risk of individuals dying from cancer by their 85th birthday will be one in five.

Author: Simon Herrmann Jun 23, 2017

Errors

Sign Up for Free Trial
Subscribe
Recent Tweets
Recent News